Calendar

 

Past events

4 - 6 November 2026

PIC/S Seminar 2026 in Istanbul (Türkiye)

The Turkish Medicines and Medical Devices Agency is pleased to host the 2026 PIC/S Seminar on “Digital Transformation in GMP” in Istanbul (Türkiye) from 4-6 November 2026, preceded by the PIC/S Committee meeting.

The Seminar is the main annual international training event by PIC/S which is open to GMP Inspectors from PIC/S Participating Authorities (PAs), (Pre-)Applicants, Partners and non-PIC/S Member Medicines Regulatory Authorities. 

For more information, please contact the PIC/S Secretariat

More
21 - 23 October 2026

PIC/S Expert Circle Meeting on Human Blood, Tissues, Cells and ATMPs in Brussels (Belgium)

Belgium’s Federal Agency for Medicines and Health Products (FAMHP) is pleased to host the 28th PIC/S Expert Circle on Human Blood, Tissues, Cells and ATMPs on 21-23 October 2026 in Brussels (Belgium).

The meeting will focus on progress updates to PIC/S guidelines and inspection aide-memoires for Blood, Tissues and Cells Establishments, and ATMPs, as well as discussions on current challenges, ATMP research and production, and the sharing of inspection experiences to improve consistency among inspectors, and will consist of presentations and workshops.

The meeting is open to Inspectors of PIC/S Participating Authorities, PIC/S Applicants and Pre-Applicants, PIC/S Partners and other interested non-PIC/S Regulatory Authorities in the field of human blood, tissues, and cells (including ATMPs).

15 - 17 September 2026

PMDA-ATC GMP Inspection Seminar 2026

The Pharmaceuticals and Medical Devices Agency (PMDA) is pleased to organise the PMDA-ATC GMP Inspection Seminar 2026, with the support of PIC/S, in Tokyo /Japan, in person, from 15 to 17 September 2026.

This Seminar is intended exclusively for overseas GMP Inspectors (Regulators only), and is aligned with the PIC/S training framework. It also serves as a pre-learning opportunity for the PIC/S 2026 Seminar in Istanbul.

The programme will focus on the PIC/S GMP Annex 22 (Artificial Intelligence) draft guidance, advanced technologies in pharmaceutical manufacturing, and GMP inspection reliance, particularly in Asia. The Seminar aims to enhance inspection capabilities and promote collaboration and shared understanding among participating authorities. 

For further information:

Flyer

PMDA webpage

More